Precision Oncology in the Age of AI: Racing Against Cancer

The promise of precision oncology is that therapy should follow the molecular properties of a tumour rather than its location - which requires interpreting a volume of genomic and clinical data no human can survey. The talk shows where artificial intelligence helps today in evaluating cancer-genetic data, identifying biomarkers and supporting personalised treatment decisions, and how much it shortens the path from genetic report to therapeutic decision. The talk closes the programme of the AI Healthcare Summit.